PF-07261271
/ Pfizer, Roche
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
March 19, 2024
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
(clinicaltrials.gov)
- P1 | N=35 | Completed | Sponsor: Pfizer | Active, not recruiting ➔ Completed
Trial completion
October 23, 2023
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
(clinicaltrials.gov)
- P1 | N=35 | Active, not recruiting | Sponsor: Pfizer | Trial completion date: Nov 2023 ➔ Feb 2024 | Trial primary completion date: Nov 2023 ➔ Feb 2024
Trial completion date • Trial primary completion date
September 28, 2023
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
(clinicaltrials.gov)
- P1 | N=35 | Active, not recruiting | Sponsor: Pfizer | Trial completion date: Aug 2024 ➔ Nov 2023 | Trial primary completion date: Aug 2024 ➔ Nov 2023
Trial completion date • Trial primary completion date
June 29, 2023
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
(clinicaltrials.gov)
- P1 | N=40 | Active, not recruiting | Sponsor: Pfizer | Recruiting ➔ Active, not recruiting
Enrollment closed
October 31, 2022
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
(clinicaltrials.gov)
- P1 | N=51 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open
September 10, 2022
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
(clinicaltrials.gov)
- P1 | N=51 | Not yet recruiting | Sponsor: Pfizer
New P1 trial
1 to 6
Of
6
Go to page
1